Oct
05

Employer interest in addressing the metabolic health crisis remains high as the cost of GLP-1 drugs and other medical treatments continues to place considerable strain on health benefit budgets. Notably, 51% of organizations currently have a weight management solution in place (2026 Brown & Brown Health Care Strategy Survey), and the metabolic health marketplace remains highly dynamic—with significant venture capital investment flowing to both established players and new entrants.

Given this environment, HR and benefits leaders face the difficult challenge of understanding the fundamental differences among a growing list of metabolic health solutions and selecting the option that best aligns with the needs of their covered populations.